INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2016
Net Assets |
£194m |
Net Assets per share |
493p |
Share price |
430p |
Total value of unquoted investments |
£22m |
Total number of portfolio companies |
86 |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
8.5 |
Biogen |
8.5 |
Celgene |
8.1 |
Gilead |
7.0 |
Regeneron |
6.6 |
Alexion |
3.7 |
Genmab |
3.7 |
Vertex |
2.9 |
Ophthotech |
2.9 |
Chimerix |
2.6 |
|
----------- |
Total |
54.5 |
Portfolio Profitability |
% NAV |
Profitable |
57 |
Turning Profitable 2016 |
6 |
Unprofitable |
37 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
85 |
Europe & UK |
15 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
89 |
Unquoted |
11 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
12 FEBRUARY 2016